{"id":6160,"date":"2017-03-15T10:05:45","date_gmt":"2017-03-15T14:05:45","guid":{"rendered":"https:\/\/medicarereport.org\/?p=6160"},"modified":"2017-03-15T10:05:45","modified_gmt":"2017-03-15T14:05:45","slug":"sticker-shock-forces-thousands-of-cancer-patients-to-skip-drugs-skimp-on-treatment","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=6160","title":{"rendered":"Sticker Shock Forces Thousands Of Cancer Patients To Skip Drugs, Skimp On Treatment"},"content":{"rendered":"

(By Liz Szabo for Kaiser Health News)<\/p>\n

John Krahne received alarming news from his doctor last December. His brain tumors were stable, but his lung tumors had grown noticeably larger.<\/p>\n

The doctor recommended a drug called Alecensa, which sells for more than $159,000 a year. Medicare would charge Krahne a $3,200 copay in December, then another $3,200 in January, as a new year of coverage kicked in.<\/p>\n

For the first time since being diagnosed 10 years ago, Krahne, now 65, decided to delay filling his prescription, hoping that his cancer wouldn\u2019t take advantage of the lapse and wreak further havoc on his body. Continue reading article here…<\/a><\/p>\n

Kaiser Health News\u00a0is\u00a0a nonprofit national health policy news service that is part of the nonpartisan Henry J. Kaiser Family Foundation.<\/p>\n

\"khn-logo1\"<\/a><\/p>\n

Notice<\/strong>: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"
(By Liz Szabo for Kaiser Health News) John Krahne received alarming news from his doctor last December. His brain tumors<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6,15],"tags":[],"class_list":["post-6160","post","type-post","status-publish","format-standard","hentry","category-medicare-general","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/6160","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6160"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/6160\/revisions"}],"predecessor-version":[{"id":6161,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/6160\/revisions\/6161"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6160"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=6160"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=6160"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}